Endpoints News ٢٤ نوفمبر ٢٠٢٥ J&J’s tau-targeting antibody fails Phase 2 Alzheimer's study #fails Phase #Alzheimer study
BioPharma Dive ٢٤ نوفمبر ٢٠٢٥ Bayer’s experimental blood-thinner notches trial win in stroke prevention #Asundexian Phase #prevention Asundexian
BioWorld ٢٤ نوفمبر ٢٠٢٥ Bayer’s asundexian hits phase III stroke goal in win for FXIa drugs #phase III #drugs Detailed
BioWorld ٢٤ نوفمبر ٢٠٢٥ Novo’s semaglutide fails in phase III Alzheimer’s trials #phase III #III Alzheimer
BioWorld ٢٤ نوفمبر ٢٠٢٥ Novo’s semaglutide fails in phase III Alzheimer’s trials #III Alzheimer #phase III
Endpoints News ٢١ نوفمبر ٢٠٢٥ Contineum's J&J-partnered drug fails Phase 2 multiple sclerosis trial #Thursday afternoon #fails Phase
Roche Media ١٨ نوفمبر ٢٠٢٥ Roche reports positive Phase III data of giredestrant for breast cancer - Clinical Trials Arena #Phase III #Clinical Trials
Roche Media ١١ نوفمبر ٢٠٢٥ Roche sizes up first BTK inhibitor approval on Phase III MS victory - Clinical Trials Arena #Phase III #Clinical Trials
Roche Media ١٠ نوفمبر ٢٠٢٥ Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed - Fierce Biotech #BTK inhibitor #Fierce Biotech
Roche Media ٣ نوفمبر ٢٠٢٥ Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint - Clinical Trials Arena #Phase III #III trial